Delivery Order SPE2DR25D2009-SPE2DR26FJ2Z5
- Not listed
- The Defense Logistics Agency awarded a $3,455.97 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. This is a firm fixed price, non-competitive set-aside contract with an ultimate completion date of June 2, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a $17,428.58 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulation. This competitively awarded, firm fixed-price contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $5,554.06 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml formulations. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, executing through November 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,893.47 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials. This non-competitive, firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical procurement within the...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.3K to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml formulations. This competitively awarded, non-set-aside contract was executed on April 28, 2025, with an ultimate completion date of April 29, 2025, and is priced on a firm fixed-price basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $12,095.40 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL vials. This competitively awarded, firm fixed-price contract is set to conclude on October 24, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single procurement action under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,777.68 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award, made on November 5, 2025, with an ultimate completion date of November 6, 2025, utilizes firm fixed-price pricing under a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.98 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml vials. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 26, 2025. The award was issued on September 25, 2025, and the pharmaceutical will be delivered to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $17,977.94 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulations. The order was competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a firm fixed-price transaction with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,324.69 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ2Z5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,819.78 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This non-competitive, firm fixed-price delivery order was issued on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a substantial portfolio of federal contracts with the Defense Logistics Agency and serves critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting history demonstrates extensive experience delivering a broad range of pharmaceutical products, specialty medications, and medical supplies across multiple therapeutic domains through competitively awarded, firm fixed-price delivery orders under its prime DLA contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 11/12/25 |